The Society for Clinical Neuropsychology (SCN)
0 FOLLOWERS
The Society for Clinical Neuropsychology (SCN), Division 40 of the American Psychological Association, is a scientific and professional organization of psychologists interested in the study of brain-behavior relationships, and the clinical application of that knowledge to human problems.
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
CONTRIBUTOR: Joshua Sensenbaugh, B.S.- Wright State University, School of Professional Psychology, Psy.D. Program (Doctoral Student) OVERVIEW: Fetal Alcohol Spectrum Disorders (FASD) is an umbrella term for a group of neurocognitive and behavioral difficulties that are brought upon by prenatal alcohol exposure (1). Studies have estimated that the prevalence of FASD within the U.S. ranges from 1 to 5% of children (2-3). The clinical features of FASD often include: prenatal growth deficiency, minor facial anomalies, problems with various organ systems, neurocognitive deficits, and self ..read more
The Society for Clinical Neuropsychology (SCN)
4y ago
The Society for Clinical Neuropsychology (SCN)
4y ago
Contributor: Daniella Ladowski, M.Sc., University of Western Ontario (Doctoral Candidate) Topic overview: Amyotrophic Lateral Sclerosis (ALS), also referred to as motor neuron disease, is a progressive disease affecting both upper and lower motor neurons. According to the El Escorial criteria [1] and its revisions [2-5], diagnosis is largely based on clinical and electrophysiological evidence of motor neuron dysfunction to the exclusion of other motor disorders. However, ALS may be conceptualized as a collection of disorders with numerous phenotypic variants, each with its own implica ..read more
The Society for Clinical Neuropsychology (SCN)
4y ago
Contributor: Yosefa Allegra Ehrlich, M.Phil., Ph.D. Candidate in Clinical Psychology, Queens College, City University of New York (CUNY) Overview: The use of biomarkers in diagnosing Alzheimer’s disease (AD) in vivo is gaining popularity. Biomarkers refer to measureable characteristics that indicate the presence of biologic and/or pathologic processes (1). This shift is based on an expanding body of research indicating that in vivo methods validly estimate post-mortem AD pathologic changes that characterize the disease (2–5). The goals of incorporating biomarkers into the diagnosis in ..read more
The Society for Clinical Neuropsychology (SCN)
4y ago
Contributor: Briana Brukilacchio, M.Ed., The University of Texas at Austin, PhD Program in School Psychology Topic Overview An estimated 15% of all patients with focal epilepsy syndromes do not experience substantial relief when treated with anticonvulsant medications alone [1]. For these patients with intractable epilepsy, surgical intervention is often indicated [2]. In order to maximize postoperative benefits and minimize the risk of associated impairments, such patients undergo presurgical epilepsy evaluations prior to treatment [3]. Evaluations are conducted by a multidisciplina ..read more